Immunogenicity and Safety of High-Dose Trivalent Inactivated Influenza Vaccine Compared to Standard-Dose Vaccine in Children and Young Adults with Cancer or HIV Infection

BACKGROUND: Approaches to improve the immune response of immunocompromised patients to influenza vaccination are needed. METHODS: Children and young adults (3–21 years) with cancer or HIV infection were randomized to receive 2 doses of high-dose (HD) trivalent influenza vaccine (TIV) or of standard-...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Vaccine
Main Authors: Hakim, Hana, Allison, Kim J., Van de Velde, Lee-Ann, Tang, Li, Sun, Yilun, Flynn, Patricia M., McCullers, Jonathan A.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899146/
https://ncbi.nlm.nih.gov/pubmed/27129426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.04.053
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki